{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:53:13Z","timestamp":1781542393294,"version":"3.54.5"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["701125509"],"award-info":[{"award-number":["701125509"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["414786233"],"award-info":[{"award-number":["414786233"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["325931972"],"award-info":[{"award-number":["325931972"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["413326622"],"award-info":[{"award-number":["413326622"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["455784452"],"award-info":[{"award-number":["455784452"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["461704389"],"award-info":[{"award-number":["461704389"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["553712603"],"award-info":[{"award-number":["553712603"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is projected to become the second leading cause of cancer-related death within this decade. Here, we show that its major driver oncogene KRAS activates the cGAS-STING-TBK1 axis, inducing a type I interferon (IFN) response that primes PDAC cells for necroptosis. Using genetically engineered mouse models, we find that cancer cell-specific deletion of caspase-8 is sufficient to trigger necroptotic cell death, eliminating most pancreatic precursor lesions. Mechanistically, KRAS-driven IFN signalling induces ISGF3-dependent expression of necroptosis-related interferon-stimulated genes, including MLKL. This renders PDAC cells selectively vulnerable to necroptosis upon caspase-8 inhibition. Therapeutically, pharmacologic caspase inhibition reduces tumour burden in aggressive PDAC models and human patient-derived organoids. A pan-cancer transcriptomic analysis links necroptosis gene expression with Ras pathway activity and IFN signatures across multiple tumour types. These findings reveal a KRAS-induced IFN program that sensitises tumour cells to necroptosis, highlighting a therapeutic vulnerability in PDAC with broader relevance across IFN-activated cancers.<\/jats:p>","DOI":"10.1038\/s41467-026-73189-8","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:37:22Z","timestamp":1781534242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8232-496X","authenticated-orcid":false,"given":"Sofya","family":"Tishina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9055-0695","authenticated-orcid":false,"given":"Alina","family":"Dahlhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1099-997X","authenticated-orcid":false,"given":"Marta","family":"Manik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejla","family":"Mulalic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1079-2545","authenticated-orcid":false,"given":"Janine","family":"Murr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6486-3898","authenticated-orcid":false,"given":"Michael","family":"Kotliar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Rakhsh-Khorshid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrto","family":"Kostopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Hocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Stroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley M.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3626-007X","authenticated-orcid":false,"given":"G\u00fclce G.","family":"Balta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali T.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7841-7493","authenticated-orcid":false,"given":"Christina M.","family":"Bebber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4160-7664","authenticated-orcid":false,"given":"Moritz","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan K. M.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Quaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1306-2169","authenticated-orcid":false,"given":"Johannes","family":"Br\u00e4gelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9870-0966","authenticated-orcid":false,"given":"Manolis","family":"Pasparakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0234-7094","authenticated-orcid":false,"given":"Filippo","family":"Beleggia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2084-1803","authenticated-orcid":false,"given":"Siddharth","family":"Balachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Trauzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2662-1281","authenticated-orcid":false,"given":"Gianmaria","family":"Liccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8613-1890","authenticated-orcid":false,"given":"Igor","family":"Astsaturov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8611-5639","authenticated-orcid":false,"given":"Maximilian","family":"Reichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadne","family":"Androulidaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7816-5919","authenticated-orcid":false,"given":"Silvia","family":"von Karstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"73189_CR1","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/cam4.767","volume":"5","author":"AS Quante","year":"2016","unstructured":"Quante, A. S. et al. Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030. Cancer Med. 5, 2649\u20132656 (2016).","journal-title":"Cancer Med."},{"key":"73189_CR2","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1053\/j.gastro.2018.12.038","volume":"156","author":"VP Balachandran","year":"2019","unstructured":"Balachandran, V. P., Beatty, G. L. & Dougan, S. K. Broadening the impact of immunotherapy to pancreatic cancer: challenges and opportunities. Gastroenterology 156, 2056\u20132072 (2019).","journal-title":"Gastroenterology"},{"key":"73189_CR3","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913\u20132921 (2014).","journal-title":"Cancer Res."},{"key":"73189_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","volume":"32","author":"BJ Raphael","year":"2017","unstructured":"Raphael, B. J. et al. Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell 32, 185\u2013203.e13 (2017).","journal-title":"Cancer Cell"},{"key":"73189_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47\u201352 (2016).","journal-title":"Nature"},{"key":"73189_CR6","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 47, 1168\u20131178 (2015).","journal-title":"Nat. Genet."},{"key":"73189_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson, E. A. et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 17, 500\u2013503 (2011).","journal-title":"Nat. Med."},{"key":"73189_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc969","volume":"3","author":"J Downward","year":"2003","unstructured":"Downward, J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3, 11\u201322 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"73189_CR9","doi-asserted-by":"publisher","first-page":"a031518","DOI":"10.1101\/cshperspect.a031518","volume":"8","author":"AJ Aguirre","year":"2018","unstructured":"Aguirre, A. J. & Hahn, W. C. Synthetic lethal vulnerabilities in KRAS-mutant cancers. Cold Spring Harb. Perspect. Med. 8, a031518 (2018).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"73189_CR10","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1073\/pnas.1821323116","volume":"116","author":"JKM Lim","year":"2019","unstructured":"Lim, J. K. M. et al. Cystine\/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance. Proc. Natl. Acad. Sci. USA 116, 2705\u20132710 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73189_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41418-022-01096-8","volume":"30","author":"F M\u00fcller","year":"2023","unstructured":"M\u00fcller, F. et al. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation. Cell Death Differ. 30, 605\u2013619 (2023).","journal-title":"Cell Death Differ."},{"key":"73189_CR12","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1053\/j.gastro.2010.02.046","volume":"138","author":"FJH Hoogwater","year":"2010","unstructured":"Hoogwater, F. J. H. et al. Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells. Gastroenterology 138, 2357\u20132367 (2010).","journal-title":"Gastroenterology"},{"key":"73189_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ccell.2015.02.014","volume":"27","author":"Karstedt","year":"2015","unstructured":"Karstedt et al. Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis. Cancer Cell 27, 561\u2013573 (2015).","journal-title":"Cancer Cell"},{"key":"73189_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S1074-7613(00)80609-3","volume":"9","author":"EE Varfolomeev","year":"1998","unstructured":"Varfolomeev, E. E. et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas\/Apo1, and DR3 and is lethal prenatally. Immunity 9, 267\u2013276 (1998).","journal-title":"Immunity"},{"key":"73189_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrc.2017.28","volume":"17","author":"S Karstedt","year":"2017","unstructured":"Karstedt, S., von, Montinaro, A. & Walczak, H. Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy. Nat. Rev. Cancer 17, 352\u2013366 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"73189_CR16","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S1074-7613(00)80212-5","volume":"12","author":"FC Kischkel","year":"2000","unstructured":"Kischkel, F. C. et al. Apo2L\/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12, 611\u2013620 (2000).","journal-title":"Immunity"},{"key":"73189_CR17","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.celrep.2013.08.045","volume":"5","author":"R Weinlich","year":"2013","unstructured":"Weinlich, R. et al. Protective roles for Caspase-8 and cFLIP in adult homeostasis. Cell Rep. 5, 340\u2013348 (2013).","journal-title":"Cell Rep."},{"key":"73189_CR18","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.immuni.2020.04.002","volume":"52","author":"R Schwarzer","year":"2020","unstructured":"Schwarzer, R., Jiao, H., Wachsmuth, L., Tresch, A. & Pasparakis, M. FADD and Caspase-8 regulate gut homeostasis and inflammation by controlling MLKL- and GSDMD-mediated death of intestinal epithelial cells. Immunity 52, 978\u2013993.e6 (2020).","journal-title":"Immunity"},{"key":"73189_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.immuni.2016.07.016","volume":"45","author":"S Alvarez-Diaz","year":"2016","unstructured":"Alvarez-Diaz, S. et al. The pseudokinase MLKL and the kinase RIPK3 have distinct roles in autoimmune disease caused by loss of death-receptor-induced apoptosis. Immunity 45, 513\u2013526 (2016).","journal-title":"Immunity"},{"key":"73189_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature09857","volume":"471","author":"WJ Kaiser","year":"2011","unstructured":"Kaiser, W. J. et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature 471, 368\u2013372 (2011).","journal-title":"Nature"},{"key":"73189_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nature09852","volume":"471","author":"A Oberst","year":"2011","unstructured":"Oberst, A. et al. Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis. Nature 471, 363\u2013367 (2011).","journal-title":"Nature"},{"key":"73189_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature01063","volume":"419","author":"HJ Chun","year":"2002","unstructured":"Chun, H. J. et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419, 395\u2013399 (2002).","journal-title":"Nature"},{"key":"73189_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/75007","volume":"6","author":"T Teitz","year":"2000","unstructured":"Teitz, T. et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat. Med. 6, 529\u2013535 (2000).","journal-title":"Nat. Med."},{"key":"73189_CR24","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1158\/0008-5472.CAN-12-2681","volume":"73","author":"T Teitz","year":"2013","unstructured":"Teitz, T. et al. Th-MYCN mice with Caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis. Cancer Res. 73, 4086\u20134097 (2013).","journal-title":"Cancer Res."},{"key":"73189_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nature04323","volume":"439","author":"DG Stupack","year":"2006","unstructured":"Stupack, D. G. et al. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 439, 95\u201399 (2006).","journal-title":"Nature"},{"key":"73189_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.lungcan.2007.11.005","volume":"60","author":"LL Belyanskaya","year":"2008","unstructured":"Belyanskaya, L. L. et al. TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2\/DR5 expression in the absence of caspase-8. Lung Cancer 60, 355\u2013365 (2008).","journal-title":"Lung Cancer"},{"key":"73189_CR27","doi-asserted-by":"publisher","first-page":"8510","DOI":"10.1038\/sj.onc.1205941","volume":"21","author":"N Shivapurkar","year":"2002","unstructured":"Shivapurkar, N. et al. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification. Oncogene 21, 8510\u20138514 (2002).","journal-title":"Oncogene"},{"key":"73189_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22336-4","volume":"12","author":"CM Bebber","year":"2021","unstructured":"Bebber, C. M. et al. Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes. Nat. Commun. 12, 2048 (2021).","journal-title":"Nat. Commun."},{"key":"73189_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-67142-4","volume":"16","author":"A Androulidaki","year":"2025","unstructured":"Androulidaki, A. et al. Lack of caspase 8 directs neuronal progenitor-like reprogramming and small cell lung cancer progression. Nat. Commun. 16, 11280 (2025).","journal-title":"Nat. Commun."},{"key":"73189_CR30","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.molcel.2019.12.023","volume":"77","author":"I M\u00fcller","year":"2020","unstructured":"M\u00fcller, I. et al. Cancer cells employ nuclear caspase-8 to overcome the p53-dependent G2\/M checkpoint through cleavage of USP28. Mol. Cell 77, 970\u2013984.e7 (2020).","journal-title":"Mol. Cell"},{"key":"73189_CR31","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1053\/j.gastro.2011.08.037","volume":"141","author":"C Liedtke","year":"2011","unstructured":"Liedtke, C. et al. Loss of Caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury. Gastroenterology 141, 2176\u20132187 (2011).","journal-title":"Gastroenterology"},{"key":"73189_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ccell.2017.08.010","volume":"32","author":"Y Boege","year":"2017","unstructured":"Boege, Y. et al. A dual role of Caspase-8 in triggering and sensing proliferation-associated DNA damage, a key determinant of liver cancer development. Cancer Cell 32, 342\u2013359.e10 (2017).","journal-title":"Cancer Cell"},{"key":"73189_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56493-7","volume":"16","author":"AT Schneider","year":"2025","unstructured":"Schneider, A. T. et al. A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development. Nat. Commun. 16, 1765 (2025).","journal-title":"Nat. Commun."},{"key":"73189_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nature17403","volume":"532","author":"L Seifert","year":"2016","unstructured":"Seifert, L. et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature 532, 245\u2013249 (2016).","journal-title":"Nature"},{"key":"73189_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2540-6","volume":"16","author":"R Janky","year":"2016","unstructured":"Janky, R. et al. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma. BMC Cancer 16, 632 (2016).","journal-title":"BMC Cancer"},{"key":"73189_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ccr.2009.07.016","volume":"16","author":"H Pei","year":"2009","unstructured":"Pei, H. et al. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16, 259\u2013266 (2009).","journal-title":"Cancer Cell"},{"key":"73189_CR37","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","volume":"184","author":"L Cao","year":"2021","unstructured":"Cao, L. et al. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell 184, 5031\u20135052.e26 (2021).","journal-title":"Cell"},{"key":"73189_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33290-0","volume":"13","author":"P East","year":"2022","unstructured":"East, P. et al. RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma. Nat. Commun. 13, 5632 (2022).","journal-title":"Nat. Commun."},{"key":"73189_CR39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","volume":"4","author":"SR Hingorani","year":"2003","unstructured":"Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437\u2013450 (2003).","journal-title":"Cancer Cell"},{"key":"73189_CR40","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/dvg.20335","volume":"45","author":"MD Muzumdar","year":"2007","unstructured":"Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global double-fluorescent Cre reporter mouse. Genesis 45, 593\u2013605 (2007).","journal-title":"Genesis"},{"key":"73189_CR41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature10400","volume":"477","author":"C G\u00fcnther","year":"2011","unstructured":"G\u00fcnther, C. et al. Caspase-8 regulates TNF-alpha induced epithelial necroptosis and terminal ileitis. Nature 477, 335\u2013339 (2011).","journal-title":"Nature"},{"key":"73189_CR42","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1084\/jem.20090616","volume":"206","author":"A Kovalenko","year":"2009","unstructured":"Kovalenko, A. et al. Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease. J. Exp. Med. 206, 2161\u20132177 (2009).","journal-title":"J. Exp. Med."},{"key":"73189_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213\u2013227 (2012).","journal-title":"Cell"},{"key":"73189_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ncb2883","volume":"16","author":"Z Cai","year":"2014","unstructured":"Cai, Z. et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat. Cell Biol. 16, 55\u201365 (2014).","journal-title":"Nat. Cell Biol."},{"key":"73189_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","volume":"54","author":"H Wang","year":"2014","unstructured":"Wang, H. et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol. Cell 54, 133\u2013146 (2014).","journal-title":"Mol. Cell"},{"key":"73189_CR46","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/s41418-024-01313-6","volume":"31","author":"K Kelepouras","year":"2024","unstructured":"Kelepouras, K. et al. The importance of murine phospho-MLKL-S345 in situ detection for necroptosis assessment in vivo. Cell Death Differ. 31, 897\u2013909 (2024).","journal-title":"Cell Death Differ."},{"key":"73189_CR47","doi-asserted-by":"publisher","first-page":"339ra69","DOI":"10.1126\/scitranslmed.aad3099","volume":"8","author":"G Brumatti","year":"2016","unstructured":"Brumatti, G. et al. The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia. Sci. Transl. Med. 8, 339ra69 (2016).","journal-title":"Sci. Transl. Med."},{"key":"73189_CR48","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1126\/science.1249361","volume":"343","author":"K Newton","year":"2014","unstructured":"Newton, K. et al. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis. Science 343, 1357\u20131360 (2014).","journal-title":"Science"},{"key":"73189_CR49","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/j.celrep.2019.07.077","volume":"28","author":"SL Orozco","year":"2019","unstructured":"Orozco, S. L. et al. RIPK3 activation leads to cytokine synthesis that continues after loss of cell membrane integrity. Cell Rep. 28, 2275\u20132287.e5 (2019).","journal-title":"Cell Rep."},{"key":"73189_CR50","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/imr.12536","volume":"277","author":"S Orozco","year":"2017","unstructured":"Orozco, S. & Oberst, A. RIPK3 in cell death and inflammation: the good, the bad, and the ugly. Immunol. Rev. 277, 102\u2013112 (2017).","journal-title":"Immunol. Rev."},{"key":"73189_CR51","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/bs.ircmb.2016.08.007","volume":"328","author":"K Moriwaki","year":"2017","unstructured":"Moriwaki, K. & Chan, F. K.-M. The inflammatory signal adaptor RIPK3: functions beyond necroptosis. Int. Rev. Cell Mol. Biol. 328, 253\u2013275 (2017).","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"73189_CR52","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/cdd.2016.46","volume":"23","author":"K Newton","year":"2016","unstructured":"Newton, K. et al. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death Differ. 23, 1565\u20131576 (2016).","journal-title":"Cell Death Differ."},{"key":"73189_CR53","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ccell.2020.08.015","volume":"38","author":"L Gabitova-Cornell","year":"2020","unstructured":"Gabitova-Cornell, L. et al. Cholesterol pathway inhibition induces TGF-\u03b2 signaling to promote basal differentiation in pancreatic cancer. Cancer Cell 38, 567\u2013583.e11 (2020).","journal-title":"Cancer Cell"},{"key":"73189_CR54","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","volume":"9","author":"G Biffi","year":"2019","unstructured":"Biffi, G. et al. IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma. Cancer Discov. 9, 282\u2013301 (2019).","journal-title":"Cancer Discov."},{"key":"73189_CR55","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","volume":"10","author":"CX Dominguez","year":"2020","unstructured":"Dominguez, C. X. et al. Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy. Cancer Discov. 10, 232\u2013253 (2020).","journal-title":"Cancer Discov."},{"key":"73189_CR56","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccr.2012.10.025","volume":"22","author":"JL Kopp","year":"2012","unstructured":"Kopp, J. L. et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 22, 737\u2013750 (2012).","journal-title":"Cancer Cell"},{"key":"73189_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08831-9","volume":"10","author":"I Angelidis","year":"2019","unstructured":"Angelidis, I. et al. An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics. Nat. Commun. 10, 963 (2019).","journal-title":"Nat. Commun."},{"key":"73189_CR58","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera, A., Soehnlein, O. & Kenne, E. Neutrophils in chronic inflammatory diseases. Cell. Mol. Immunol. 19, 177\u2013191 (2022).","journal-title":"Cell. Mol. Immunol."},{"key":"73189_CR59","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2111537119","volume":"119","author":"W Li","year":"2022","unstructured":"Li, W. et al. Necroptosis triggers spatially restricted neutrophil-mediated vascular damage during lung ischemia reperfusion injury. Proc. Natl. Acad. Sci. USA 119, e2111537119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73189_CR60","doi-asserted-by":"publisher","first-page":"D852","DOI":"10.1093\/nar\/gkn732","volume":"37","author":"SA Samarajiwa","year":"2009","unstructured":"Samarajiwa, S. A., Forster, S., Auchettl, K. & Hertzog, P. J. INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res. 37, D852\u2013D857 (2009).","journal-title":"Nucleic Acids Res."},{"key":"73189_CR61","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0378-1119(99)00419-9","volume":"240","author":"Y Fu","year":"1999","unstructured":"Fu, Y. et al. Cloning of DLM-1, a novel gene that is up-regulated in activated macrophages, using RNA differential display. Gene 240, 157\u2013163 (1999).","journal-title":"Gene"},{"key":"73189_CR62","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nature06013","volume":"448","author":"A Takaoka","year":"2007","unstructured":"Takaoka, A. et al. DAI (DLM-1\/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448, 501\u2013505 (2007).","journal-title":"Nature"},{"key":"73189_CR63","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neo.2018.11.002","volume":"21","author":"A-K Knuth","year":"2019","unstructured":"Knuth, A.-K. et al. Interferons transcriptionally up-regulate MLKL expression in cancer cells. Neoplasia 21, 74\u201381 (2019).","journal-title":"Neoplasia"},{"key":"73189_CR64","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1158\/2159-8290.CD-22-1066","volume":"13","author":"SB Kemp","year":"2023","unstructured":"Kemp, S. B. et al. Efficacy of a small molecule inhibitor of KrasG12D in immunocompetent models of pancreatic cancer. Cancer Discov. 13, 298\u2013311 (2023).","journal-title":"Cancer Discov."},{"key":"73189_CR65","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/emboj.2010.7","volume":"29","author":"M Drosten","year":"2010","unstructured":"Drosten, M. et al. Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. EMBO J. 29, 1091\u20131104 (2010).","journal-title":"EMBO J."},{"key":"73189_CR66","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nature25459","volume":"554","author":"S Mueller","year":"2018","unstructured":"Mueller, S. et al. Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes. Nature 554, 62\u201368 (2018).","journal-title":"Nature"},{"key":"73189_CR67","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","volume":"29","author":"J Peng","year":"2019","unstructured":"Peng, J. et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 29, 725\u2013738 (2019).","journal-title":"Cell Res."},{"key":"73189_CR68","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41591-018-0302-5","volume":"25","author":"H Liu","year":"2019","unstructured":"Liu, H. et al. Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss. Nat. Med. 25, 95\u2013102 (2019).","journal-title":"Nat. Med."},{"key":"73189_CR69","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s43018-022-00468-w","volume":"3","author":"N Samson","year":"2022","unstructured":"Samson, N. & Ablasser, A. The cGAS-STING pathway and cancer. Nat. Cancer 3, 1452\u20131463 (2022).","journal-title":"Nat. Cancer"},{"key":"73189_CR70","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41586-023-06621-4","volume":"622","author":"S Victorelli","year":"2023","unstructured":"Victorelli, S. et al. Apoptotic stress causes mtDNA release during senescence and drives the SASP. Nature 622, 627\u2013636 (2023).","journal-title":"Nature"},{"key":"73189_CR71","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout, A., Katz, J. D., Venkatraman, S. & Ablasser, A. The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases. Nat. Rev. Immunol. 21, 548\u2013569 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"73189_CR72","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature07317","volume":"455","author":"H Ishikawa","year":"2008","unstructured":"Ishikawa, H. & Barber, G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674\u2013678 (2008).","journal-title":"Nature"},{"key":"73189_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10970-y","volume":"10","author":"E Platanitis","year":"2019","unstructured":"Platanitis, E. et al. A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription. Nat. Commun. 10, 2921 (2019).","journal-title":"Nat. Commun."},{"key":"73189_CR74","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cell.2015.05.053","volume":"162","author":"F Dietlein","year":"2015","unstructured":"Dietlein, F. et al. A synergistic interaction between Chk1- and MK2 inhibitors in KRAS-mutant cancer. Cell 162, 146\u2013159 (2015).","journal-title":"Cell"},{"key":"73189_CR75","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.molcel.2017.05.003","volume":"66","author":"I Jaco","year":"2017","unstructured":"Jaco, I. et al. MK2 phosphorylates RIPK1 to prevent TNF-induced cell death. Mol. Cell 66, 698\u2013710.e5 (2017).","journal-title":"Mol. Cell"},{"key":"73189_CR76","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139837","volume":"5","author":"B Uzunparmak","year":"2020","unstructured":"Uzunparmak, B. et al. Caspase-8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic\u2013induced necroptosis. JCI Insight 5, e139837 (2020).","journal-title":"JCI Insight"},{"key":"73189_CR77","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1158\/2159-8290.CD-15-0896","volume":"6","author":"S-H Chen","year":"2016","unstructured":"Chen, S.-H. et al. Oncogenic BRAF deletions that function as homodimers and are sensitive to inhibition by RAF dimer inhibitor LY3009120. Cancer Discov. 6, 300\u2013315 (2016).","journal-title":"Cancer Discov."},{"key":"73189_CR78","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","volume":"7","author":"SR Hingorani","year":"2005","unstructured":"Hingorani, S. R. et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469\u2013483 (2005).","journal-title":"Cancer Cell"},{"key":"73189_CR79","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.137809","volume":"5","author":"Z Dantes","year":"2020","unstructured":"Dantes, Z. et al. Implementing cell-free DNA of pancreatic cancer patient\u2013derived organoids for personalized oncology. JCI Insight 5, e137809 (2020).","journal-title":"JCI Insight"},{"key":"73189_CR80","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.trecan.2022.09.003","volume":"9","author":"H Cheon","year":"2023","unstructured":"Cheon, H., Wang, Y., Wightman, S. M., Jackson, M. W. & Stark, G. R. How cancer cells make and respond to interferon-I. Trends Cancer 9, 83\u201392 (2023).","journal-title":"Trends Cancer"},{"key":"73189_CR81","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ccr.2007.07.001","volume":"12","author":"J Deng","year":"2007","unstructured":"Deng, J. et al. BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents. Cancer Cell 12, 171\u2013185 (2007).","journal-title":"Cancer Cell"},{"key":"73189_CR82","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","volume":"575","author":"J Canon","year":"2019","unstructured":"Canon, J. et al. The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity. Nature 575, 217\u2013223 (2019).","journal-title":"Nature"},{"key":"73189_CR83","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl6464","volume":"10","author":"M Cole","year":"2024","unstructured":"Cole, M. et al. Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responses. Sci. Adv. 10, eadl6464 (2024).","journal-title":"Sci. Adv."},{"key":"73189_CR84","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1158\/2159-8290.CD-19-0620","volume":"10","author":"N Muthalagu","year":"2020","unstructured":"Muthalagu, N. et al. Repression of the type I interferon pathway underlies MYC- and KRAS-dependent evasion of NK and B cells in pancreatic ductal adenocarcinoma. Cancer Discov. 10, 872\u2013887 (2020).","journal-title":"Cancer Discov."},{"key":"73189_CR85","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.immuni.2023.05.017","volume":"56","author":"M Vucur","year":"2023","unstructured":"Vucur, M. et al. Sublethal necroptosis signaling promotes inflammation and liver cancer. Immunity 56, 1578\u20131595.e8 (2023).","journal-title":"Immunity"},{"key":"73189_CR86","doi-asserted-by":"publisher","first-page":"e0228015","DOI":"10.1371\/journal.pone.0228015","volume":"15","author":"Y Ando","year":"2020","unstructured":"Ando, Y. et al. Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5. PLoS ONE 15, e0228015 (2020).","journal-title":"PLoS ONE"},{"key":"73189_CR87","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41418-019-0347-0","volume":"27","author":"S Patel","year":"2020","unstructured":"Patel, S. et al. RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases. Cell Death Differ. 27, 161\u2013175 (2020).","journal-title":"Cell Death Differ."},{"key":"73189_CR88","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2207240119","volume":"119","author":"DA Rodriguez","year":"2022","unstructured":"Rodriguez, D. A. et al. Caspase-8 and FADD prevent spontaneous ZBP1 expression and necroptosis. Proc. Natl. Acad. Sci. USA 119, e2207240119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73189_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111434","volume":"41","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Molecular mechanism of RIPK1 and caspase-8 in homeostatic type I interferon production and regulation. Cell Rep. 41, 111434 (2022).","journal-title":"Cell Rep."},{"key":"73189_CR90","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada, E. et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 9, 1102\u20131123 (2019).","journal-title":"Cancer Discov."},{"key":"73189_CR91","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund, D. et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J. Exp. Med. 214, 579\u2013596 (2017).","journal-title":"J. Exp. Med."},{"key":"73189_CR92","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrc.2016.14","volume":"16","author":"BS Parker","year":"2016","unstructured":"Parker, B. S., Rautela, J. & Hertzog, P. J. Antitumour actions of interferons: implications for cancer therapy. Nat. Rev. Cancer 16, 131\u2013144 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"73189_CR93","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1056\/NEJMoa2105281","volume":"384","author":"MM Awad","year":"2021","unstructured":"Awad, M. M. et al. Acquired resistance to KRASG12C inhibition in cancer. N. Engl. J. Med. 384, 2382\u20132393 (2021).","journal-title":"N. Engl. J. Med."},{"key":"73189_CR94","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cell.2007.10.037","volume":"131","author":"JE Vince","year":"2007","unstructured":"Vince, J. E. et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 131, 682\u2013693 (2007).","journal-title":"Cell"},{"key":"73189_CR95","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cell.2007.10.030","volume":"131","author":"E Varfolomeev","year":"2007","unstructured":"Varfolomeev, E. et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131, 669\u2013681 (2007).","journal-title":"Cell"},{"key":"73189_CR96","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1158\/2159-8290.CD-20-1202","volume":"11","author":"E Espinet","year":"2021","unstructured":"Espinet, E. et al. Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell of origin. Cancer Discov. 11, 638\u2013659 (2021).","journal-title":"Cancer Discov."},{"key":"73189_CR97","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.molcel.2018.01.027","volume":"69","author":"A Annibaldi","year":"2018","unstructured":"Annibaldi, A. et al. Ubiquitin-mediated regulation of RIPK1 kinase activity independent of IKK and MK2. Mol. Cell 69, 566\u2013580.e5 (2018).","journal-title":"Mol. Cell"},{"key":"73189_CR98","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.4049\/jimmunol.175.6.3469","volume":"175","author":"DR Beisner","year":"2005","unstructured":"Beisner, D. R., Ch\u2019en, I. L., Kolla, R. V., Hoffmann, A. & Hedrick, S. M. Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J. Immunol. 175, 3469\u20133473 (2005).","journal-title":"J. Immunol."},{"key":"73189_CR99","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s41418-024-01321-6","volume":"31","author":"L K\u00f6rner","year":"2024","unstructured":"K\u00f6rner, L. et al. ZBP1 causes inflammation by inducing RIPK3-mediated necroptosis and RIPK1 kinase activity-independent apoptosis. Cell Death Differ. 31, 938\u2013953 (2024).","journal-title":"Cell Death Differ."},{"key":"73189_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-06773-w","volume":"20","author":"D Tawfik","year":"2020","unstructured":"Tawfik, D. et al. The A818\u20136 system as an in-vitro model for studying the role of the transportome in pancreatic cancer. BMC Cancer 20, 264 (2020).","journal-title":"BMC Cancer"},{"key":"73189_CR101","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/sj.bjc.6601330","volume":"89","author":"A Trauzold","year":"2003","unstructured":"Trauzold, A. et al. Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells. Br. J. Cancer 89, 1714\u20131721 (2003).","journal-title":"Br. J. Cancer"},{"key":"73189_CR102","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169105","volume":"10","author":"K Wittenzellner","year":"2025","unstructured":"Wittenzellner, K. et al. Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real time. JCI Insight 10, e169105 (2025).","journal-title":"JCI Insight"},{"key":"73189_CR103","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.151353","volume":"7","author":"F Orben","year":"2022","unstructured":"Orben, F. et al. Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtype. JCI Insight 7, e151353 (2022).","journal-title":"JCI Insight"},{"key":"73189_CR104","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels, P. A. et al. The nf-core framework for community-curated bioinformatics pipelines. Nat. Biotechnol. 38, 276\u2013278 (2020).","journal-title":"Nat. Biotechnol."},{"key":"73189_CR105","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nbt.3820","volume":"35","author":"PD Tommaso","year":"2017","unstructured":"Tommaso, P. D. et al. Nextflow enables reproducible computational workflows. Nat. Biotechnol. 35, 316\u2013319 (2017).","journal-title":"Nat. Biotechnol."},{"key":"73189_CR106","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"73189_CR107","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"73189_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"73189_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100989","volume":"2","author":"A Surumbayeva","year":"2021","unstructured":"Surumbayeva, A. et al. Preparation of mouse pancreatic tumor for single-cell RNA sequencing and analysis of the data. STAR Protoc. 2, 100989 (2021).","journal-title":"STAR Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73189-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73189-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73189-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:04:41Z","timestamp":1781539481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73189-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73189"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73189-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"21 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5288"}}